[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioventus Inc Cl A (BVS)

Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 747,638
  • Shares Outstanding, K 83,535
  • Annual Sales, $ 568,090 K
  • Annual Income, $ 22,730 K
  • EBIT $ 65 M
  • EBITDA $ 112 M
  • 60-Month Beta 0.67
  • Price/Sales 1.33
  • Price/Cash Flow 7.09
  • Price/Book 3.22

Options Overview Details

View History
  • Implied Volatility 75.19% (+8.26%)
  • Historical Volatility 59.60%
  • IV Percentile 16%
  • IV Rank 15.87%
  • IV High 308.26% on 11/19/25
  • IV Low 31.23% on 09/04/25
  • Expected Move (DTE 8) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 9
  • Volume Avg (30-Day) 121
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 3,886
  • Open Int (30-Day) 3,887
  • Expected Range 9.20 to 9.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.21
  • Number of Estimates 2
  • High Estimate $0.22
  • Low Estimate $0.20
  • Prior Year $0.21
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.81 +17.80%
on 06/02/26
11.00 -16.36%
on 05/20/26
-1.30 (-12.38%)
since 05/08/26
3-Month
7.81 +17.80%
on 06/02/26
11.25 -18.22%
on 05/07/26
+0.59 (+6.85%)
since 03/09/26
52-Week
5.81 +58.35%
on 08/05/25
11.25 -18.22%
on 05/07/26
+2.48 (+36.90%)
since 06/09/25

Most Recent Stories

More News
Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference

DURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President...

BVS : 9.20 (+2.79%)
Bioventus: Q1 Earnings Snapshot

Bioventus: Q1 Earnings Snapshot

BVS : 9.20 (+2.79%)
Bioventus Reports First Quarter Financial Results

Q1 reported revenue of $132.1 million increased 7% First quarter GAAP earnings of $0.04 per diluted share compared to the prior-year period loss of $0.04 per diluted share Non-GAAP...

BVS : 9.20 (+2.79%)
Bioventus Reports Tomorrow With Peripheral Nerve Stimulation Launch Still Unproven

Barchart Research What to Expect from BVS Earnings BVS Generated May 5, 2026 Current Price $10.68 EPS Estimate $$0.09 Consensus Rating Strong Buy Average Move 18.73% Bioventus Reports Tomorrow With Peripheral...

BVS : 9.20 (+2.79%)
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

MALVERN, Pa., April 30, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today...

AXGN : 42.87 (+3.40%)
TELA : 0.9352 (+10.02%)
ANIK : 14.57 (-0.21%)
MDXG : 3.71 (+0.27%)
ELUT : 0.9700 (-2.04%)
BVS : 9.20 (+2.79%)
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026

DURHAM, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will...

BVS : 9.20 (+2.79%)
Bioventus: Q4 Earnings Snapshot

Bioventus: Q4 Earnings Snapshot

BVS : 9.20 (+2.79%)
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results

Q4 reported revenue of $157.9 million increased 2.8% and organic* revenue increased 10.0% Fourth quarter GAAP earnings of $0.21 per diluted share compared to $0.00 in the prior-year period Non-GAAP...

BVS : 9.20 (+2.79%)
Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026

DURHAM, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”) , a global leader in innovations for active healing, today announced that it will...

BVS : 9.20 (+2.79%)
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference

DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Chief Executive Officer, will present...

BVS : 9.20 (+2.79%)

Business Summary

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

See More

Key Turning Points

3rd Resistance Point 9.66
2nd Resistance Point 9.48
1st Resistance Point 9.34
Last Price 9.20
1st Support Level 9.02
2nd Support Level 8.84
3rd Support Level 8.70

See More

52-Week High 11.25
Last Price 9.20
Fibonacci 61.8% 9.17
Fibonacci 50% 8.53
Fibonacci 38.2% 7.89
52-Week Low 5.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.